224 related articles for article (PubMed ID: 37120674)
1. Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.
Markowska M; Budzinska MA; Coenen-Stass A; Kang S; Kizling E; Kolmus K; Koras K; Staub E; Szczurek E
Sci Rep; 2023 Apr; 13(1):7049. PubMed ID: 37120674
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
Weng S; Ruan H
FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
[TBL] [Abstract][Full Text] [Related]
3. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
4. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
[TBL] [Abstract][Full Text] [Related]
5. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
6. Computational methods, databases and tools for synthetic lethality prediction.
Wang J; Zhang Q; Han J; Zhao Y; Zhao C; Yan B; Dai C; Wu L; Wen Y; Zhang Y; Leng D; Wang Z; Yang X; He S; Bo X
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35352098
[TBL] [Abstract][Full Text] [Related]
7. Overcoming selection bias in synthetic lethality prediction.
Seale C; Tepeli Y; Gonçalves JP
Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
[TBL] [Abstract][Full Text] [Related]
8. Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cells.
Parkhitko AA; Singh A; Hsieh S; Hu Y; Binari R; Lord CJ; Hannenhalli S; Ryan CJ; Perrimon N
PLoS Genet; 2021 Feb; 17(2):e1009354. PubMed ID: 33591981
[TBL] [Abstract][Full Text] [Related]
9. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
10. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
[TBL] [Abstract][Full Text] [Related]
11.
Sun N; Petiwala S; Lu C; Hutti JE; Hu M; Hu M; Domanus MH; Mitra D; Addo SN; Miller CP; Chung N
CRISPR J; 2019 Aug; 2():230-245. PubMed ID: 31436504
[TBL] [Abstract][Full Text] [Related]
12. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
Banerjee S; Roy S
Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
[TBL] [Abstract][Full Text] [Related]
13. Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality.
Benfatto S; Serçin Ö; Dejure FR; Abdollahi A; Zenke FT; Mardin BR
Mol Cancer; 2021 Aug; 20(1):111. PubMed ID: 34454516
[TBL] [Abstract][Full Text] [Related]
14. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.
Zangene E; Marashi SA; Montazeri H
Sci Rep; 2023 Sep; 13(1):15763. PubMed ID: 37737478
[TBL] [Abstract][Full Text] [Related]
15. Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Carbajosa S; Pansa MF; Paviolo NS; Castellaro AM; Andino DL; Nigra AD; García IA; Racca AC; Rodriguez-Berdini L; Angiolini V; Guantay L; Villafañez F; Federico MB; Rodríguez-Baili MC; Caputto BL; Drewes G; Madauss KP; Gloger I; Fernandez E; Gil GA; Bocco JL; Gottifredi V; Soria G
Clin Cancer Res; 2019 Jul; 25(13):4049-4062. PubMed ID: 30890549
[TBL] [Abstract][Full Text] [Related]
16. Using graph-based model to identify cell specific synthetic lethal effects.
Pu M; Cheng K; Li X; Xin Y; Wei L; Jin S; Zheng W; Peng G; Tang Q; Zhou J; Zhang Y
Comput Struct Biotechnol J; 2023; 21():5099-5110. PubMed ID: 37920819
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response.
Kciuk M; Gielecińska A; Mujwar S; Mojzych M; Kontek R
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408915
[TBL] [Abstract][Full Text] [Related]
18. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
Guo J; Liu H; Zheng J
Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
[TBL] [Abstract][Full Text] [Related]
19. A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
Apaolaza I; San José-Enériz E; Valcarcel LV; Agirre X; Prosper F; Planes FJ
PLoS Comput Biol; 2022 Mar; 18(3):e1009395. PubMed ID: 35286311
[TBL] [Abstract][Full Text] [Related]
20. SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.
Deng X; Das S; Valdez K; Camphausen K; Shankavaram U
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31671773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
